Home NDC 42858-404-45 APTENSIO XR
Product NDC 42858-404
Requested package NDC 42858-404-45
11-digit product format 428580404
Labeler code 42858
Product ID 42858-404_9468380f-2590-4c7a-9451-81776fa2cfaf
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name (methylphenidate hydrochloride)
Dosage form CAPSULE, EXTENDED RELEASE
Route ORAL
Labeler Rhodes Pharmaceuticals L.P.
Application NDA205831
Marketing category NDA
Marketing start 2015-04-17
Marketing end 0000-00-00
Substance METHYLPHENIDATE HYDROCHLORIDE
Active strength 30 mg/1
Pharmacologic classes Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]
DEA schedule CII
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 7 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205831-001 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-002 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-003 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-004 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-005 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-006 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 N205831-007 APTENSIO XR METHYLPHENIDATE HYDROCHLORIDE 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 7 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 8 · 315 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-006 APTENSIO XR 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205831-007 APTENSIO XR 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-006 APTENSIO XR 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205831-007 APTENSIO XR 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17 c2088c7a36db…2026-09-14 22:38:34 2026-08 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-006 APTENSIO XR 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205831-007 APTENSIO XR 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17 84e616aacf4f…2026-08-18 06:07:40 2026-07 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-006 APTENSIO XR 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205831-007 APTENSIO XR 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-006 APTENSIO XR 50MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205831-007 APTENSIO XR 60MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD, RS 2015-04-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205831-001 APTENSIO XR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205831-002 APTENSIO XR 15MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205831-003 APTENSIO XR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205831-004 APTENSIO XR 30MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205831-005 APTENSIO XR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB3 RLD 2015-04-17 31067a03dcf5…
Observed Orange Book normalized TE history# Normalized TE history page 2 of 8 · 315 observed states.
Observed Orange Book patent history# Patent history page 1 of 15 · 567 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N205831-001 10039719 2019-12-16 U-2357 2018-08-15 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 6419960 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7083808 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7247318 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7438930 2019-12-16 Drug product, Delist requested 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 8580310 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 9066869 2019-12-16 Drug product 2015-07-27 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 9801823 2019-12-16 Drug product 2017-11-29 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 10039719*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 6419960*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7083808*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7247318*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 7438930*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 8580310*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 9066869*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-001 9801823*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 10039719 2019-12-16 U-2357 2018-08-15 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 6419960 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7083808 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7247318 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7438930 2019-12-16 Drug product, Delist requested 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 8580310 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 9066869 2019-12-16 Drug product 2015-07-27 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 9801823 2019-12-16 Drug product 2017-11-29 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 10039719*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 6419960*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7083808*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7247318*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 7438930*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 8580310*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 9066869*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-002 9801823*PED 2020-06-16 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 10039719 2019-12-16 U-2357 2018-08-15 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 6419960 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 7083808 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 7247318 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 7438930 2019-12-16 Drug product, Delist requested 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 8580310 2019-12-16 Drug product 2015-05-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 9066869 2019-12-16 Drug product 2015-07-27 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205831-003 9801823 2019-12-16 Drug product 2017-11-29 74a2ff9319b5…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded METHYLPHENIDATE HYDROCHLORIDE ACTIVE INGREDIENT 4B3SC438HI APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 METHYLPHENIDATE ACTIVE MOIETY 207ZZ9QZ49 APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 AMMONIO METHACRYLATE COPOLYMER TYPE B INACTIVE INGREDIENT 161H3B14U2 APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 D&C RED NO. 28 INACTIVE INGREDIENT 767IP0Y5NH APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 D&C RED NO. 33 INACTIVE INGREDIENT 9DBA0SBB0L APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 FD&C GREEN NO. 3 INACTIVE INGREDIENT 3P3ONR6O1S APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 FD&C RED NO. 3 INACTIVE INGREDIENT PN2ZH5LOQY APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 GELATIN INACTIVE INGREDIENT 2G86QN327L APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A INACTIVE INGREDIENT NX76LV5T8J APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 SUCROSE INACTIVE INGREDIENT C151H8M554 APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 TALC INACTIVE INGREDIENT 7SEV7J4R1U APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 TRIETHYL CITRATE INACTIVE INGREDIENT 8Z96QXD6UM APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5 WATER INACTIVE INGREDIENT 059QF0KO0R APTENSIO XR ((METHYLPHENIDATE HYDROCHLORIDE)) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42858-404 APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RHODES PHARMACEUTICALS L.P.] 13 Legacy NDC 20240410_5adedc01-ebf0-11e3-ac10-0800200c9a66.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 42858-404-45 42858040445 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-404-45) 2015-04-17 0000-00-00 No No Current